4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy

A.R. Naqash; C.R.G. Stroud; C. Cherry; M. Muzaffar; M. Bowling; P.R. Walker

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy

【24h】

4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy

机译：4A.03通过反编程细胞死亡-1（PD-1）治疗治疗的先期肺癌中C反应蛋白（CRP）的预测效用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共1页
作者
A.R. Naqash; C.R.G. Stroud; C. Cherry; M. Muzaffar; M. Bowling; P.R. Walker;
展开▼
作者单位

Hematology/Oncology East Carolina University/Vidant Medical Center;

Hematology/Oncology East Carolina University/Vidant Medical Center;

Hematology Oncology East Carolina University Brody School of Medicine;

Hematology/Oncology East Carolina University;

Pulmonary Critical Care East Carolina University Brody School of Medicine;

Hematology/Oncology Brody School of Medicine at East Carolina University;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy [J] . A.R. Naqash, C.R.G. Stroud, C. Cherry, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：4A.03通过反编程细胞死亡-1（PD-1）治疗治疗的先期肺癌中C反应蛋白（CRP）的预测效用
2. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database [J] . Naqash Abdul Rafeh, Stroud Chipman Robert Geoffrey, Butt Muhammad Umer, Acta oncologica. . 2018,第6期

机译：用反向细胞死亡1治疗治疗的晚期非小细胞肺癌外周血炎性生物标志物的整体存活共同关系：单一制度数据库的结果
3. 32?C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study [J] . Abdul Rafeh Naqash, Alessio Cortellini, Emma Mi, Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期

机译：32？C-反应蛋白（CRP）作为具有免疫检查点抑制剂的先进非小细胞肺癌的预后生物标志物。多中心国际观察研究结果
4. Chemotherapy in Advanced Stage Non-small Cell Lung Cancer - Have We Got the Evidence [C] . R.P. Perng, Y.M. Chen Asian Pacific Society of Respirology . 2003

机译：化疗在晚期非小细胞肺癌 - 我们有证据吗？
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Co-relation of Overall Survival with Peripheral Blood-Based Inflammatory Biomarkers in Advanced Stage Non-Small Cell Lung Cancer Treated with Anti-Programmed Cell Death-1 Therapy: Results from a Single Institutional Database [O] . Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, -1

机译：用抗程序性细胞死亡1治疗治疗的晚期非小细胞肺癌的整体生存与外周血基于炎症的生物标志物的相互关系：单个机构数据库的结果
7. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database [O] . Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, 2017

机译：用反向细胞死亡治疗治疗的晚期非小细胞肺癌外周血炎性生物标志物的整体生存共同关系：单一制度数据库的结果

4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy

著录项

相似文献

相关主题

期刊订阅